Anti-PD-1(Opdivo)(Nivolumab biosimilar) mAb
Order now and get it on Tuesday May 30, 2023
Same day delivery FREE on San Diego area orders placed by 1.00 PM
|Amount :||100 µg|
|Purification :||Purified from cell culture supernatant by affinity chromatography|
|Storage condition :||Store at -20°C to -80°C (Avoid repeated freezing and thawing).|
Nivolumab (Optivo), Pembrolizumab are both PD-1 inhibitors. PD-1 is a "checkpoint" protein on immune cells that alerts them not to attack cells that express PD-L1. Some cancer cells express PD-L1, which enables them to “switch off” an immune system response. Monoclonal antibodies such as pembrolizumab and nivolumab block this signaling between PD-1 and PD-L1 and thereby reinforce the immune system response to tumor cells.
Research grade biosimilar. Not for use in therapeutic or diagnostic procedures for humans or animals.
ELISA 1:5000-10000, FACS 1:100
For Research Use Only. Not for use in diagnostic/therapeutics procedures.
There are currently no product reviews